Novel fentanyl derivatives as counteracting agents against fentanyl
作为芬太尼对抗剂的新型芬太尼衍生物
基本信息
- 批准号:10175594
- 负责人:
- 金额:$ 12.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-30 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdministrative SupplementAdultAffinityAminesAwardBindingBiological AssayCell LineCentral Nervous System AgentsChemical StructureChemical WarfareChemicalsChronicCrystallizationDangerousnessDevelopmentDoseEffectivenessExposure toFamilyFatality rateFemaleFentanylFoodFundingFunding MechanismsGoalsGrantHalf-LifeIn VitroInfusion proceduresLeadLifeLocationMolecularMorphineMusNaloxoneOpioidOpioid AntagonistOpioid ReceptorOutcomeOverdoseParentsPilot ProjectsPopulationProceduresPropertyProteinsResearchRouteSeriesSkeletonStructureStructure-Activity RelationshipTestingTimeToxic effectUnited States National Institutes of HealthVentilatory DepressionWateracute toxicityaerosolizedanalogbasechemical synthesischemical threatcombatcompare effectivenesscomputational chemistrydesigndrug candidatedrug developmentdrug discoveryemergency service responderin vivointerestmalemedical countermeasuremolecular modelingmouse modelmu opioid receptorsnovelopioid overdoseopioid use disorderpharmacokinetics and pharmacodynamicsradioligandreceptorresearch and developmentresponsesynthetic opioidtherapy development
项目摘要
Project Summary
This proposal is in response to the Notice of Special Interest (NOT-NS-20-030): Administrative Supplements to
Promote and Expand into the Research and Development of Medical Countermeasures Against Chemical
Threats. We plan to pursue the development of novel and potent fentanyl derivatives as mu opioid receptor
(MOR) modulators to counteract the acute exposure to potent synthetic opioid threat, i.e. fentanyl and its analogs.
The fentanyls are a large family of synthetic opioids and are prominent on the list of potential chemical threats.
The fact that some of them are up to 10,000-fold more potent than morphine and they can be aerosolized or
placed into food/water makes the potential of a chemical attack using them becoming real. Designer fentanyls
can be synthesized at a single location and are readily available on the street. Because of their high potency and
longer half-life than naloxone, the front-line treatment for fentanyl overdose, multiple infusions and high doses of
naloxone may be required during reversal procedure. Emergency responders often have a limited supply of
naloxone, which could easily be depleted. All these may lead to higher fatality rate if a large population is under
attack. Recently we have identified a novel molecular mechanism of fentanyl binding and activation on its target
protein, the MOR, through systematic computational chemistry studies. Accordingly, we plan to apply these
molecular modeling findings to design novel MOR modulators based on the structural skeleton of phenylfentanil,
a neutral antagonist on the MOR, and to study their potential to specifically reverse the function of fentanyl and
its analogs on the MOR more effectively and specifically. Following the completion of this pilot project, we plan
to establish a dynamic and continuous drug discovery and development pipeline to combat the acute toxicity of
the opioid threat.
项目摘要
本提案是对特别关注通知(NOT-NS-20-030)的回应:
推动和拓展化学品医学对策的研究与开发
威胁我们计划继续开发新型和有效的芬太尼衍生物作为μ阿片受体
(MOR)调节剂,以抵消急性暴露于强效合成阿片样物质的威胁,即芬太尼及其类似物。
芬太尼是合成阿片类药物的一个大家族,在潜在化学威胁名单上很突出。
事实上,它们中的一些比吗啡的效力高出10,000倍,并且它们可以雾化或
放置在食物/水中使得使用它们的化学攻击的可能性变得真实的。设计师芬太尼
可以在单一位置合成,并且在街上很容易获得。由于其高效能和
半衰期长于纳洛酮,芬太尼过量的一线治疗,多次输注和高剂量
在逆转过程中可能需要纳洛酮。应急响应人员通常只有有限的
纳洛酮很容易被耗尽这些都可能导致更高的死亡率,如果人口众多,
攻击最近,我们发现了一种新的芬太尼结合和激活其靶点的分子机制
蛋白质,莫尔,通过系统的计算化学研究。因此,我们计划应用这些
基于苯基芬太尼的结构骨架设计新型莫尔调节剂的分子模拟发现,
莫尔的中性拮抗剂,并研究其特异性逆转芬太尼功能的潜力,
其类似物对莫尔的作用更有效和更特异。在完成这项试验计划后,我们计划
建立一个动态和持续的药物发现和开发管道,以对抗急性毒性,
鸦片威胁
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YAN ZHANG其他文献
YAN ZHANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YAN ZHANG', 18)}}的其他基金
Enhance the security and resilience of the national food safety system
增强国家食品安全体系的安全性和韧性
- 批准号:
10783485 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
Development of Specific Mu Opioid Receptor Antagonists to Reverse the Acute and Chronic Toxicity of Fentanyls
开发特异性 Mu 阿片受体拮抗剂以逆转芬太尼的急性和慢性毒性
- 批准号:
10476705 - 财政年份:2022
- 资助金额:
$ 12.5万 - 项目类别:
Microbiology - Whole Genome Sequencing Analytical Track
微生物学 - 全基因组测序分析轨道
- 批准号:
10441905 - 财政年份:2020
- 资助金额:
$ 12.5万 - 项目类别:
Microbiology - Whole Genome Sequencing Analytical Track
微生物学 - 全基因组测序分析轨道
- 批准号:
10173193 - 财政年份:2020
- 资助金额:
$ 12.5万 - 项目类别:
Whole genome sequencing for outbreak investigations of foodborne pathogens and antimicrobial resistance studies for FDA Vet-LIRN
用于食源性病原体爆发调查的全基因组测序和 FDA Vet-LIRN 的抗菌药物耐药性研究
- 批准号:
10471716 - 财政年份:2019
- 资助金额:
$ 12.5万 - 项目类别:
Whole genome sequencing for outbreak investigations of foodborne pathogens and antimicrobial resistance studies for FDA Vet-LIRN
用于食源性病原体爆发调查的全基因组测序和 FDA Vet-LIRN 的抗菌药物耐药性研究
- 批准号:
10207647 - 财政年份:2019
- 资助金额:
$ 12.5万 - 项目类别:
Mu Opioid Receptor Modulator Development to Treat Opioid Use Disorder
Mu 阿片受体调节剂开发用于治疗阿片类药物使用障碍
- 批准号:
10671268 - 财政年份:2019
- 资助金额:
$ 12.5万 - 项目类别:
Mu Opioid Receptor Modulator Development to Treat Opioid Use Disorder
Mu 阿片受体调节剂开发用于治疗阿片类药物使用障碍
- 批准号:
10023180 - 财政年份:2019
- 资助金额:
$ 12.5万 - 项目类别:
Mu Opioid Receptor Modulator Development to Treat Opioid Use Disorder
Mu 阿片受体调节剂开发用于治疗阿片类药物使用障碍
- 批准号:
9904032 - 财政年份:2019
- 资助金额:
$ 12.5万 - 项目类别:
Whole genome sequencing for outbreak investigations of foodborne pathogens and antimicrobial resistance studies for FDA Vet-LIRN
用于食源性病原体爆发调查的全基因组测序和 FDA Vet-LIRN 的抗菌药物耐药性研究
- 批准号:
9916178 - 财政年份:2019
- 资助金额:
$ 12.5万 - 项目类别:
相似海外基金
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
- 批准号:
10833895 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
- 批准号:
10841820 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
- 批准号:
10850135 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
- 批准号:
10896844 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
- 批准号:
10840220 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
- 批准号:
10844667 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
- 批准号:
10891050 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
- 批准号:
10711717 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
- 批准号:
10811292 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别:
Administrative Supplement: Genome Resources for Model Amphibians
行政补充:模型两栖动物基因组资源
- 批准号:
10806365 - 财政年份:2023
- 资助金额:
$ 12.5万 - 项目类别: